BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36972979)

  • 1. Diagnosis and treatment outcomes from prebronchodilator spirometry performed alongside lung cancer screening in a Lung Health Check programme.
    Bradley C; Boland A; Clarke L; Dallinson N; Eckert C; Ellames D; Finn J; Gabe R; Hancock N; Kennedy MP; Lindop J; Mohamed A; Mullen G; Murray RL; Rogerson S; Shinkins B; Simmonds I; Upperton S; Wilkinson A; Crosbie PA; Callister ME
    Thorax; 2023 Jun; 78(6):543-550. PubMed ID: 36972979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
    Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
    Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
    [No Abstract]   [Full Text] [Related]  

  • 3. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
    Balata H; Harvey J; Barber PV; Colligan D; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Mellor S; Newton T; Sawyer R; Sharman A; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Whittaker J; Vestbo J; Booton R; Crosbie PA
    Thorax; 2020 Aug; 75(8):655-660. PubMed ID: 32444437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD.
    Bradley C; Alexandris P; Baldwin DR; Booton R; Darby M; Eckert CJ; Gabe R; Hancock N; Janes S; Kennedy M; Lindop J; Neal RD; Rogerson S; Shinkins B; Simmonds I; Upperton S; Vestbo J; Crosbie PAJ; Callister MEJ
    ERJ Open Res; 2023 Jul; 9(4):. PubMed ID: 37609601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometry.
    Tisi S; Dickson JL; Horst C; Quaife SL; Hall H; Verghese P; Gyertson K; Bowyer V; Levermore C; Mullin AM; Teague J; Farrelly L; Nair A; Devaraj A; Hackshaw A; ; Hurst JR; Janes SM
    Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35896207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.
    Undrunas A; Kasprzyk P; Rajca A; Kuziemski K; Rzyman W; Zdrojewski T
    BMJ Open; 2022 Apr; 12(4):e055007. PubMed ID: 35410926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we be screening for COPD? - looking through the lens of lung cancer screening.
    Young RP; Scott RJ
    Expert Rev Respir Med; 2023; 17(9):753-771. PubMed ID: 37728077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
    Fu SN; Yu WC; Wong CK; Lam MC
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2391-2399. PubMed ID: 27729780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voluntary lung function screening to reveal new COPD cases in southern Italy.
    Capozzolo A; Castellana G; Dragonieri S; Carratù P; Liotino V; Vulpi MR; Marra L; Resta E; Intiglietta P; Resta O
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2035-2042. PubMed ID: 28744118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes.
    Fortis S; Eberlein M; Georgopoulos D; Comellas AP
    BMJ Open Respir Res; 2017; 4(1):e000213. PubMed ID: 29435342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undiagnosed and 'overdiagnosed' COPD using postbronchodilator spirometry in primary healthcare settings: a systematic review and meta-analysis.
    Perret J; Yip SWS; Idrose NS; Hancock K; Abramson MJ; Dharmage SC; Walters EH; Waidyatillake N
    BMJ Open Respir Res; 2023 Apr; 10(1):. PubMed ID: 37130651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spirometric testing on World COPD Day.
    Grzetic-Romcevic T; Devcic B; Sonc S
    Int J Chron Obstruct Pulmon Dis; 2011; 6():141-6. PubMed ID: 21468166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.
    Sekine Y; Fujisawa T; Suzuki K; Tsutatani S; Kubota K; Ikegami H; Isobe Y; Nakamura M; Takiguchi Y; Tatsumi K
    Respirology; 2014 Jan; 19(1):98-104. PubMed ID: 24033868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over diagnosis of chronic obstructive pulmonary disease in an underserved patient population.
    Ghattas C; Dai A; Gemmel DJ; Awad MH
    Int J Chron Obstruct Pulmon Dis; 2013; 8():545-9. PubMed ID: 24348030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia.
    Al Ghobain M; Al-Hajjaj MS; Wali SO
    Ann Saudi Med; 2011; 31(2):129-33. PubMed ID: 21403413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The majority of participants with abnormal spirometry at walk-in consult their general practitioner as recommended.
    Kølner-Augustson L; Thøgersen N; Faaborg TH; Weinreich UM
    Dan Med J; 2015 Nov; 62(11):A5149. PubMed ID: 26522482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study.
    Castillo D; Guayta R; Giner J; Burgos F; Capdevila C; Soriano JB; Barau M; Casan P;
    Respir Med; 2009 Jun; 103(6):839-45. PubMed ID: 19200706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.